Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance.

Xinlu Wang, Melody M H Li, Jing Zhao, Shenglan Li, Margaret R MacDonald, Charles M Rice, Xiang Gao, Guangxia Gao
Author Information
  1. Xinlu Wang: CAS Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Chaoyang District, Beijing, China.
  2. Melody M H Li: The Rockefeller University, New York, New York, USA.
  3. Jing Zhao: Model Animal Research Center, Nanjing University, Nanjing, China.
  4. Shenglan Li: CAS Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Chaoyang District, Beijing, China.
  5. Margaret R MacDonald: The Rockefeller University, New York, New York, USA.
  6. Charles M Rice: The Rockefeller University, New York, New York, USA.
  7. Xiang Gao: Model Animal Research Center, Nanjing University, Nanjing, China.
  8. Guangxia Gao: CAS Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Chaoyang District, Beijing, China gaogx@moon.ibp.ac.cn.

Abstract

Viral infection induces production of type I interferons (IFNs), which stimulate the expression of a variety of antiviral factors to inhibit viral replication. To establish effective infection, viruses need to develop strategies to evade the immune responses. A neurovirulent Sindbis virus strain with neuroinvasive properties (SVNI) causes lethal encephalitis in mice, and its replication in cultured cells is inhibited by the zinc finger antiviral protein (ZAP), a host factor that specifically inhibits the replication of certain viruses by binding to the viral mRNAs, repressing the translation of target mRNA, and promoting the degradation of target mRNA. We report here that murine embryonic fibroblast cells from ZAP knockout mice supported more efficient SVNI replication than wild-type cells. SVNI infection of 10-day-old suckling mice led to reduced survival in the knockout mice. Unexpectedly, however, SVNI infection of 23-day-old weanling mice, whose immune system is more developed than that of the suckling mice, resulted in significantly improved survival in ZAP knockout mice. Further analyses revealed that in the weanling knockout mice, SVNI replicated more efficiently in lymphoid tissues at early times postinfection and induced higher levels of IFN production, which restricted viral spread to the central nervous system. Blocking IFN activity through the use of receptor-neutralizing antibodies rendered knockout mice more sensitive to SVNI infection than wild-type mice. These results uncover a mechanism by which SVNI exploits a host antiviral factor to evade innate immune surveillance.
IMPORTANCE: Sindbis virus, a prototypic member of the Alphavirus genus, has been used to study the pathogenesis of acute viral encephalitis in mice for many years. How the virus evades immune surveillance to establish effective infection is largely unknown. ZAP is a host antiviral factor that potently inhibits Sindbis virus replication in cell culture. We show here that infection of ZAP knockout suckling mice with an SVNI led to faster disease progression. However, SVNI infection of weanling mice led to slower disease progression in knockout mice. Further analyses revealed that in weanling knockout mice, SVNI replicated more efficiently in lymphoid tissues at early times postinfection and induced higher levels of interferon production, which restricted viral spread to the central nervous system. These results uncover a mechanism by which SVNI exploits a host antiviral factor to evade innate immune surveillance and allow enhanced neuroinvasion.

References

  1. J Virol. 2007 Mar;81(5):2391-400 [PMID: 17182693]
  2. Nature. 2014 Feb 13;506(7487):245-8 [PMID: 24352241]
  3. Cell Immunol. 1986 Feb;97(2):454-9 [PMID: 3742614]
  4. J Virol. 2003 Nov;77(21):11555-62 [PMID: 14557641]
  5. Virology. 2016 Jan;487:230-41 [PMID: 26550947]
  6. Immunopharmacol Immunotoxicol. 1999 Aug;21(3):565-82 [PMID: 10466080]
  7. Immunity. 2006 Sep;25(3):373-81 [PMID: 16979569]
  8. RNA Biol. 2008 Apr-Jun;5(2):65-7 [PMID: 18418085]
  9. Cell Host Microbe. 2013 Oct 16;14(4):435-45 [PMID: 24075860]
  10. J Virol. 1999 Dec;73(12):10387-98 [PMID: 10559357]
  11. PLoS Pathog. 2013;9(7):e1003494 [PMID: 23853601]
  12. Eur J Immunol. 1993 Jul;23(7):1643-8 [PMID: 8100776]
  13. J Virol. 1993 Aug;67(8):4605-10 [PMID: 8392602]
  14. Trends Immunol. 2012 Apr;33(4):190-7 [PMID: 22321608]
  15. J Immunol. 2009 Feb 15;182(4):2297-304 [PMID: 19201884]
  16. Virology. 1964 Apr;22:651-2 [PMID: 14166127]
  17. Int Immunol. 2015 Jul;27(7):357-64 [PMID: 25758257]
  18. Arch Virol. 1992;122(3-4):237-48 [PMID: 1346243]
  19. J Virol. 2005 Nov;79(22):13974-83 [PMID: 16254333]
  20. Virology. 2003 Aug 1;312(2):415-24 [PMID: 12919746]
  21. J Virol. 2004 Dec;78(23):12781-7 [PMID: 15542630]
  22. Arch Virol. 1999;144(6):1159-71 [PMID: 10446650]
  23. Nat Commun. 2014 Nov 10;5:5362 [PMID: 25382312]
  24. EMBO J. 2012 Nov 5;31(21):4236-46 [PMID: 23023399]
  25. Mol Cell. 2011 May 20;42(4):489-99 [PMID: 21596313]
  26. Virology. 2009 Dec 5;395(1):121-32 [PMID: 19782381]
  27. J Virol. 1990 May;64(5):2041-6 [PMID: 1691310]
  28. Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1371-6 [PMID: 17227866]
  29. Nature. 2014 Jan 30;505(7485):691-5 [PMID: 24284630]
  30. Infect Immun. 1971 Feb;3(2):268-73 [PMID: 16557964]
  31. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15834-9 [PMID: 21876179]
  32. Am J Pathol. 1965 Jun;46:929-43 [PMID: 14328022]
  33. Annu Rev Biochem. 1998;67:227-64 [PMID: 9759489]
  34. J Virol. 2007 Oct;81(20):11246-55 [PMID: 17686841]
  35. Annu Rev Immunol. 2014;32:513-45 [PMID: 24555472]
  36. Virology. 1999 Oct 25;263(2):339-48 [PMID: 10544107]
  37. Cold Spring Harb Perspect Med. 2012 May;2(5):a006940 [PMID: 22553496]
  38. J Virol. 2000 Apr;74(7):3366-78 [PMID: 10708454]
  39. Cell Host Microbe. 2012 Oct 18;12(4):408-18 [PMID: 23084911]
  40. Virology. 1996 Oct 1;224(1):73-83 [PMID: 8862401]
  41. Adv Virus Res. 1989;36:255-71 [PMID: 2544083]
  42. J Virol. 1997 Apr;71(4):2636-46 [PMID: 9060616]
  43. PLoS One. 2012;7(5):e37398 [PMID: 22615998]
  44. Immunol Rev. 2008 Oct;225:27-45 [PMID: 18837774]

Grants

  1. R01 AI114873/NIAID NIH HHS

MeSH Term

Alphavirus Infections
Animals
Antiviral Agents
Cell Line
Central Nervous System
Cricetinae
Immunity, Innate
Interferon Type I
Lymphoid Tissue
Mice
Mice, Inbred C57BL
Mice, Knockout
RNA-Binding Proteins
Sindbis Virus
Virus Replication

Chemicals

Antiviral Agents
Interferon Type I
RNA-Binding Proteins
ZAP antiviral protein, mouse